Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X025908 | OT |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X023974 | — |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X010374 | OT |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y007193 | OT |
dministered improperly stored GARDASIL 9 and VAQTA following a TE; No additional AE; This spontaneous report was received from a consumer or other non health professional on 10-Mar-2025 and refers to 16-month-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. The vaccines experienced temperature excursion on 26-Oct-2024 at 25 F for 1 hour. There was no pereious temperature excursion. On an unknown date, the patient may be vaccinated with Hepatitis A Vaccine, Inactivated (lot #X025908, expiration date: 24-Apr-2025), or Human Papillomavirus 9-valent Vaccine, Recombinant (lot #Y007193, expiration date: 06-Jun-2026), or Hepatitis A Vaccine, Inactivated (lot #X023974, expiration date: 18-Apr-2025) (unknown), or Hepatitis A Vaccine, Inactivated (lot #X010374, expiration date: 13-Nov-2024) (unknown), administered as prophylaxis (due to incomplete source document, it was unknown whech specific vaccine was administered) (Product storage error). No additional AE (no adverse event).